Fate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	7.14	13.63	63.53	96.3	55.85	31.43
Revenue Growth (YoY)	-46.92%	-78.55%	-34.03%	72.44%	77.66%	194.33%
Cost of Revenue	99.54	118.53	157.19	320.45	215.52	125.62
Gross Profit	-92.41	-104.9	-93.65	-224.15	-159.67	-94.19
Selling, General & Admin	67.59	90.64	96.86	84.23	57.32	33.9
Operating Expenses	67.59	90.64	96.86	84.23	57.32	33.9
Operating Income	-159.99	-195.54	-190.51	-308.39	-216.99	-128.09
Interest & Investment Income	12.71	17.29	17.19	5.84	1.31	2.4
Other Non Operating Income (Expenses)	5.93	6.73	7.3	20.32	3.53	-47.7
EBT Excluding Unusual Items	-141.36	-171.53	-166.03	-282.22	-212.15	-173.39
Asset Writedown	-14.74	-14.74	-	-	-	-
Other Unusual Items	-	-	5.1	0.5	-	-
Pretax Income	-156.09	-186.26	-160.93	-281.72	-212.15	-173.39
Net Income	-156.09	-186.26	-160.93	-281.72	-212.15	-173.39
Net Income to Common	-156.09	-186.26	-160.93	-281.72	-212.15	-173.39
Shares Outstanding (Basic)	118	114	98	97	95	82
Shares Outstanding (Diluted)	118	114	98	97	95	82
Shares Change (YoY)	8.77%	15.52%	1.64%	2.19%	15.00%	20.82%
EPS (Basic)	-1.32	-1.64	-1.64	-2.91	-2.24	-2.10
EPS (Diluted)	-1.32	-1.64	-1.64	-2.91	-2.24	-2.10
Free Cash Flow	-115.43	-123.6	-138.42	-283.77	-213.57	-44.16
Free Cash Flow Per Share	-0.97	-1.09	-1.41	-2.93	-2.25	-0.54
Gross Margin	-	-	-147.41%	-232.77%	-285.92%	-299.64%
Operating Margin	-2241.75%	-1434.52%	-299.86%	-320.24%	-388.56%	-407.47%
Profit Margin	-2187.11%	-1366.46%	-253.30%	-292.55%	-379.89%	-551.59%
Free Cash Flow Margin	-1617.32%	-906.79%	-217.87%	-294.68%	-382.43%	-140.49%
EBITDA	-145.34	-176.58	-172.23	-294.63	-211.14	-125
EBITDA Margin	-	-	-271.09%	-	-	-
D&A For EBITDA	14.65	18.96	18.28	13.76	5.85	3.09
EBIT	-159.99	-195.54	-190.51	-308.39	-216.99	-128.09
EBIT Margin	-	-	-299.86%	-	-	-

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q